Related Experiment Video
Updated: Oct 8, 2026

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain
Nermin Kamal Saeed1, Safaa Al-Khawaja2, Jameela Alsalman2
1Medical Microbiology Section, Pathology Department, Salmaniya Medical Complex, Manama 00000, Bahrain.
Insights
Bacterial and fungal co-infections significantly increased in COVID-19 patients during the pandemic. These infections led to higher morbidity and mortality, emphasizing the need for proactive management strategies.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- The COVID-19 pandemic poses significant challenges, exacerbated by microbial co-infections.
- Bacterial and fungal co-infections increase morbidity and mortality in COVID-19 patients.
Purpose of the Study:
- To investigate the bacterial and fungal profiles in hospitalized COVID-19 patients in Bahrain.
- To analyze the resistance patterns of isolated microorganisms.
Main Methods:
- Retrospective observational study of 1380 COVID-19 patients admitted between February and October 2020.
- Analysis of electronic patient records and microbiology laboratory data.
- Identification of microbial profiles, acquisition sources (hospital vs. community), and patient outcomes.
Main Results:
- A significant increase in bacterial and fungal co-infections was observed in the latter half of 2020.
- Predominant pathogens included Gram-negative bacteria (Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii), Gram-positive bacteria (Staphylococci, Enterococci, Staphylococcus aureus), and fungi (Candida spp., Aspergillus spp.).
- Hospital-acquired infections were prevalent (73.8%), particularly in the second study period, and associated with higher mortality.
Conclusions:
- Bacterial and fungal co-infections in COVID-19 patients are linked to increased morbidity and mortality.
- Minimizing the risks associated with these co-infections is crucial for patient outcomes.
Background:
The coronavirus disease 2019 (COVID-19) pandemic presents a significant challenge to the medical profession, increasing in the presence of microbial co-infection. Bacterial and Fungal co-infections increase the risk of morbidity and mortality in patients with COVID-19.
Aim:
To study the bacterial profile in patients with COVID-19 who needed admission to receive treatment in the main centres concerned with managing COVID-19 disease in the Kingdom of Bahrain.
Methods:
The study was a retrospective observational analysis of the bacterial profile and the bacterial resistance in patients with confirmed COVID-19 disease who needed admission to receive treatment in the main centres assigned to manage patients with COVID-19 disease in the Kingdom of Bahrain from February to October 2020. We used the electronic patients' records and the microbiology laboratory data to identify patients' demographics, clinical data, microbial profile, hospital or community-acquired, and the outcomes.
Results:
The study included 1380 patients admitted with confirmed COVID-19 disease during the study period. 51% were admitted from February to June, and 49% were admitted from July to October 2020, with a recurrence rate was 0.36%. There was a significant increase in bacterial and fungal co-infection in the second period compared to the first period. The most common isolated organisms were the gram-negative bacteria (mainly Klebsiella pneumoniae, Pseudomonas aeruginosa, multi-drug resistant Acinetobacter baumannii, and Escherichia coli), the gram-positive bacteria (mainly coagulase negative Staphylococci, Enterococcus faecium, Enterococcus faecalis, Staphylococcus aureus) and fungaemia (Candida galabrata, Candida tropicalis, Candida albicans, Aspergillus fumigatus, Candida parapsilosis, Aspergillus niger). The hospital-acquired infection formed 73.8%, 61.6%, 100% gram-negative, gram-positive and fungaemia. Most of the hospital-acquired infection occurred in the second period with a higher death rate than community-acquired infections.
Conclusion:
Bacterial and fungal co-infections in patients admitted with confirmed COVID-19 disease pose higher morbidity and mortality risks than those without co-infections. We should perform every effort to minimize these risks.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Inhalation Anthrax
Bacterial Meningitis
Bacterial Gastroenteritis
Coronavirus
Respiratory Syncytial Virus Disease

